Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Gökçe Aşkan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9255-649X; OpenAlex author ID A5040241639, A5046521042. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
78
Papers, trials and grants by year

2017: 3 papers · 2018: 2 papers · 2019: 1 paper · 2020: 3 papers · 2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 14

  1. Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation. Co-author DOI 10.1016/j.devcel.2026.04.012↗
  2. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. Co-author DOI 10.1038/s41591-024-03075-7↗
  3. Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility. Co-author DOI 10.1038/s41467-021-23237-2↗
  4. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08123-w↗
  5. Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall. Co-author DOI 10.5146/tjpath.2020.01519↗
  6. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.05.010↗
  7. Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma. Co-author DOI 10.1073/pnas.1920240117↗
  8. Induction and characterization of pancreatic cancer in a transgenic pig model. Co-author DOI 10.1371/journal.pone.0239391↗
  9. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-019-02112-1↗
  10. Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancrea… Co-author DOI 10.1016/j.hpb.2017.12.010↗
  11. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-0349↗
  12. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Co-author DOI 10.1038/nature24462↗
  13. Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity? First author DOI 10.1093/annonc/mdx503↗
  14. Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype. Co-author DOI 10.1158/1078-0432.ccr-17-0899↗

Closest collaborators

The 25 strongest of 78 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Olca Baştürk · 7 shared papers, 2017–2021 · strength 0.74
  2. Christine A. Iacobuzio–Donahue · 7 shared papers, 2017–2026 · strength 0.70
  3. Steven D Leach · 6 shared papers, 2017–2026 · strength 0.55
  4. Rohit Chandwani · 3 shared papers, 2020–2026 · strength 0.39
  5. Aslihan Yavas · 2 shared papers, 2021–2026 · strength 0.34
  6. Eileen Mary O'Reilly · 3 shared papers, 2017–2021 · strength 0.29
  7. Fong Cheng Pan · 2 shared papers, 2020–2026 · strength 0.27
  8. Vinod P. Balachandran · 4 shared papers, 2017–2021 · strength 0.26
  9. İbrahim Halil Şahin · 2 shared papers, 2017–2021 · strength 0.24
  10. Peter J. Allen · 4 shared papers, 2017–2019 · strength 0.23
  11. Olivera Grbovic-Huezo · 3 shared papers, 2017–2020 · strength 0.21
  12. Adrien Grimont · 1 shared paper, 2026 · strength 0.20
  13. Xian Zhang · 1 shared paper, 2026 · strength 0.20
  14. Danwei Huangfu · 1 shared paper, 2026 · strength 0.20
  15. Jen Jen Yeh · 1 shared paper, 2026 · strength 0.20
  16. William R. Jarnagin · 3 shared papers, 2017–2019 · strength 0.19
  17. Marinela Capanu · 1 shared paper, 2021 · strength 0.14
  18. T. Peter Kingham · 2 shared papers, 2018–2019 · strength 0.14
  19. Michael Ian D'Angelica · 2 shared papers, 2018–2019 · strength 0.14
  20. Danielle C. Glassman · 2 shared papers, 2017–2021 · strength 0.14
  21. Marc A. Attiyeh · 2 shared papers, 2017–2019 · strength 0.12
  22. Matilda Holm · 1 shared paper, 2020 · strength 0.10
  23. Suhasini Joshi · 1 shared paper, 2020 · strength 0.10
  24. Kenneth L Pitter · 1 shared paper, 2020 · strength 0.10
  25. Caj H. Haglund · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.